Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM: Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders (The British Journal of Psychiatry (2018) (1-3) DOI: 10.1192/bjp.2018.24)
Publication date
2018-09
Authors
Oviedo-Salcedo, Tatiana
De Witte, Lot
Kümpfel, Tania
Kahn, René S.
Falkai, Peter
Eichhorn, Peter
Luykx, Jurjen J.
Hasan, Alkomiet
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
In the reference list, number 11 is stated incorrectly. The correct reference for 11 is: Dyalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology 2011; 10(1):63-74. The authors regret the error.
Keywords
Journal Article, Taverne, Psychiatry and Mental health, Published Erratum, Journal Article
Citation
Oviedo-Salcedo, T, de Witte, L, Kümpfel, T, Kahn, R S, Falkai, P, Eichhorn, P, Luykx, J & Hasan, A 2018, 'Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM : Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders (The British Journal of Psychiatry (2018) (1-3) DOI: 10.1192/bjp.2018.24)', British Journal of Psychiatry, vol. 213, no. 3, pp. 561. https://doi.org/10.1192/bjp.2018.77